VLP Vaccine

The VLP vaccine antigen development is based on our unique technology and follows the three key stages
  • 1) VLP production confirmation and seed development for commercialization
  • 2) Non-clinical and clinical trial of the VLP
  • 3) Licensing out or commercialization of VLP technology product.

We are developing a pipeline for various VLP based vaccines for both livestock and human use and have already succeeded in the commercialization of several vaccines.

The VLP vaccine technology we are developing is the new generation solution to the safety issues and low efficacy of existing recombinant vaccines. It has resolved low productivity rates and has simplified the complicated refinement process in existing VLP development, presenting a vast improvement in the commercial complex vaccine technology market.

top
QUICK MENU
OPTIPHARM
Xenotransplantation
VLP vaccine
Bacteriophage
Animal Dx
Medipig
QUICK MENU